logo

For the Inventor, By the Inventor

Tübingen, Germany

Reiner Lammers

This inventor holds 6 USPTO granted patents and 3 published patent applications and 4 EPO patents. Top assignees: Hoffmann-La Roche Inc., Eberhard-Karls-Universitaet Tuebingen Universitaetsklinikum, Eberhard-Karls-Universität Tuebingen Universitaetsklinikum. Active years: 2008-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Reiner Lammers. Retrieved from https://idiyas.com/inventor/reiner-lammers-osfphl8x

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 16.7

 

Average Co-Inventor Count = 3.8

ph-index = 4

Forward Citations = 27(Granted Patents)


Location History:

  • Tuebingen, DE (2008 - 2014)
  • Tubingen, DE (2015)

Company Filing History:

goldMedal3 out of 5,026 
 
Hoffmann-La Roche Inc.
 patents
silverMedal2 out of 16 
 
Eberhard-Karls-Universitaet Tuebingen Universitaetsklinikum
 patents
bronzeMedal1 out of 1 
 
Eberhard-Karls-Universität Tuebingen Universitaetsklinikum
 patent

Years Active: 2008-2015

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents
1. 9052316 - Isolation and/or identification of stem cells having adipocytic, chondrocytic and pancreatic differentiation potential (2015-06-09),
2. 8883159 - Antibodies against CDCP1 for the treatment of cancer (2014-11-11),
3. 8163495 - Method for isolating and/or identifying mesenchymal stem cells (MSC) (2012-04-24),
4. 7741114 - Antibodies for identifying and/or isolating at least one cell population (2010-06-22),
5. 7541030 - Antibodies for identifying and/or isolating at least one cell population which is selected from the group comprising haematopoietic stem cells, neuronal stem cells, neuronal precursor cells, mesenchymal stem cells and mesenchymal precursor cells (2009-06-02),
6. 7364863 - Monoclonal antibody W8B2 and method of use (2008-04-29),

Title: Reiner Lammers: Innovator in Stem Cell Research

Introduction

Reiner Lammers is a distinguished inventor based in Tuebingen, Germany. He has made significant contributions to the field of stem cell research, holding a total of 6 patents. His work focuses on the isolation and identification of stem cells with potential for various medical applications.

Latest Patents

One of his latest patents involves a method for isolating and identifying stem cells that have adipocytic, chondrocytic, and pancreatic differentiation potential. This invention utilizes an antibody that binds to the antigen TNAP, either alone or in combination with an antibody that binds to the cell surface antigen CD56. The stem cells isolated through this method are intended for treating defects, damages, or diseases in bone or cartilage in patients who require such interventions. Another notable patent pertains to antibodies against human CDCP1, which bind to the same epitope as CUB4, aimed at cancer treatment.

Career Highlights

Throughout his career, Reiner Lammers has worked with prominent organizations, including Hoffmann-La Roche Inc. and Eberhard Karls University Tuebingen Universitätsklinikum. His experience in these institutions has furthered his research and innovation in the medical field.

Collaborations

Reiner has collaborated with notable colleagues such as Hans-Joerg Buehring and Hans-Jorg Buhring, contributing to advancements in stem cell research and cancer treatment.

Conclusion

Reiner Lammers is a pivotal figure in the realm of stem cell research, with a focus on innovative methods for medical treatment. His patents and collaborations reflect his commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…